Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Addendum, Allergan, alleviation, Amylin, appoint, automatic, billion, blended, Book, Botox, BYDUREON, byHorizant, certify, complaint, conclusion, concurrent, consolidate, consolidated, convene, Database, deployment, dismissed, dispensed, draft, elbow, enable, entirety, epidemiological, epidemiology, escalate, exenatide, exploring, FDCA, flexor, forgiven, function, holder, illustrative, imposition, initialHorizant, injectable, IV, Jersey, listed, low, motion, nonclinical, onabotulinumtoxin, ongoingIn, Orange, Practice, QT, reacquired, referenced, respond, responded, Restoration, similarly, stay, sue, superiority, theIn, theNDA, thereof, tiered, UK, unchanged, uncured, wrist
Removed:
balance, evaluated, recent, resolution, venture
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.43 Consulting Letter Agreement - William J. Rieflin
- 10.44 Change of Control Agreement - Gianna M. Bosko
- 31.1 Certification of the CEO Pursuant to Rules 13A-14(A) and 15D-14(A)
- 31.2 Certification of the CFO Pursuant to Rules 13A-14(A) and 15D-14(A)
- 32.1 Certification Required by Rule 13A-14(B) or Rule 15D-14(B)
Related press release
XNPT similar filings
Filing view
External links